Yumanity Therapeutics, Inc. YMTX
Set alert
1.89 +1.89 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 15.72M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.38
- Beta
- 0.00
- Short ratio
- 1.24
- Inst. own
- 22.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 14, 2022
- 50-d avg
- 1.77
- 200-d avg
- 1.59
- 1y target
- 35.00
Analyst view
Consensus: buy
Buy
Price target (mean) 35.00
Recommendation trend
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -1.03 | 0.0% | 1.66M | -21.6% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.97 | 0.0% | 2.50M | +52.9% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 10.00M | +24.3% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 12.00M | +20.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 4, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 1, 2021 | Jefferies | Initiated | — | Buy |